Burden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Biostatistics Research Unit, South African Medical Research Council, Cape Town, South Africa.
S Afr Med J. 2022 Sep 30;112(8b):627-638. doi: 10.7196/SAMJ.2022.v112i8b.16490.
Elevated sodium consumption is associated with increased blood pressure, a major risk factor for cardiovascular and chronic kidney disease.
To quantify the deaths and disability-adjusted life years (DALYs) attributed to high sodium intake in persons aged ≥25 years in South Africa (SA) for 2000, 2006 and 2012.
Comparative risk assessment (CRA) methodology was used and population attributable fractions (PAFs) of high sodium intake, mediated through high blood pressure (BP), for cardiovascular and chronic kidney disease were estimated. This was done by taking the difference between the PAF for elevated systolic BP (SBP) based on the estimated SBP level in the population and the PAF based on the estimated SBP that would result if sodium intake levels were reduced to the theoretical minimum risk exposure level (1 g/day) according to population group and hypertension categories. A meta-regression based on data from nine national surveys conducted between 1998 and 2017 was used to estimate the prevalence of hypertension by age, sex and population group. Relative risks identified from international literature were used and the difference in PAFs was applied to local burden estimates from the second South African National Burden of Disease Study. Age-standardised rates were calculated using World Health Organization (WHO) standard population weights. The attributable burden was also estimated for 2012 using an alternative target of 2 g/day proposed in the National Strategic Plan for the Prevention and Control of Non-communicable Diseases (NSP).
High sodium intake as mediated through high SBP was estimated to cause 8 071 (95% uncertainty interval (UI) 6 542 - 15 474) deaths in 2012, a drop from 9 574 (95% UI 8 158 - 16 526) in 2006 and 8 431 (95% UI 6 972 - 14 511) in 2000. In 2012, ischaemic heart disease caused the highest number of deaths in persons (n=1 832), followed by haemorrhagic stroke (n=1 771), ischaemic stroke (n=1 484) and then hypertensive heart disease (n=1 230). Ischaemic heart disease was the highest contributor to deaths for males (27%), whereas for females it was haemorrhagic stroke (23%). In 2012, 1.5% (95% UI 1.3 - 2.9) of total deaths and 0.7% (95% UI 0.6 - 1.2) of total DALYs were attributed to high sodium intake. If the NSP target of <2 g/day sodium intake had been achieved in 2012, ~2 943 deaths and 48 870 DALYs would have been averted.
Despite a slight decreasing trend since 2006, high sodium intake mediated through raised BP accounted for a sizeable burden of disease in 2012. Realising SA's target to reduce sodium intake remains a priority, and progress requires systematic monitoring and evaluation.
摄入过多的钠会导致血压升高,而血压升高是心血管疾病和慢性肾脏病的主要危险因素。
量化 2000 年、2006 年和 2012 年南非(SA)25 岁及以上人群因高钠摄入导致的死亡人数和伤残调整生命年(DALYs)。
采用比较风险评估(CRA)方法,估计高钠摄入通过高血压导致心血管疾病和慢性肾脏病的人群归因分数(PAF)。这是通过在人群中估计的收缩压(SBP)水平的基础上,从升高的 SBP 的 PAF 中减去基于钠摄入量减少到理论最低风险暴露水平(1 克/天)的 PAF 来实现的根据人群组和高血压类别。根据 1998 年至 2017 年期间进行的九项全国性调查的数据,使用基于元回归的方法来估计按年龄、性别和人群组划分的高血压患病率。使用从国际文献中确定的相对风险,并将 PAF 差异应用于第二次南非国家疾病负担研究的当地负担估计。使用世界卫生组织(WHO)标准人口权重计算年龄标准化率。还使用 2012 年提出的 2 克/天的替代目标(NSP)来估计归因于 2012 年的负担。
估计 2012 年,高钠摄入通过升高的 SBP 导致 8071 人死亡(95%不确定区间[UI]为 6542-15474),与 2006 年的 9574 人(95%UI 为 8158-16526)和 2000 年的 8431 人(95%UI 为 6972-14511)相比有所下降。2012 年,缺血性心脏病导致的死亡人数最多(n=1832),其次是出血性中风(n=1771)、缺血性中风(n=1484)和高血压性心脏病(n=1230)。缺血性心脏病是男性死亡的主要原因(27%),而女性则是出血性中风(23%)。2012 年,1.5%(95%UI 1.3-2.9)的总死亡和 0.7%(95%UI 0.6-1.2)的总伤残调整生命年归因于高钠摄入。如果 2012 年实现了<2 克/天的 NSP 钠摄入量目标,将避免约 2943 人死亡和 48870 人伤残调整生命年。
尽管自 2006 年以来呈轻微下降趋势,但通过升高的 BP 介导的高钠摄入仍在 2012 年导致了相当大的疾病负担。实现南非减少钠摄入的目标仍然是当务之急,进展需要系统监测和评估。